A Phase-1, Open-label, Two Group, Fixed-Sequence Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers
Latest Information Update: 03 Nov 2023
At a glance
- Drugs Adafosbuvir (Primary) ; Odalasvir (Primary) ; Simeprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Alios BioPharma
- 28 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Aug 2015 New trial record